Director's Report to the National Advisory Council on Drug Abuse
September, 2001
Extramural Policy and Review Activities
Review Meetings
For this Council cycle, the Office of Extramural Affairs arranged and managed 23 review meetings for 373 applications in its standing committees, applications in conflict-of-interest with standing committees, and RFA submissions. There were an additional 13 reviews held for contract proposals, and one concept was reviewed.
The reviews for NIDA's chartered committees were held. These consist of NIDA-E (Treatment Review Committee), NIDA-F (Health Services Review Committee), NIDA-L (Medications Development Committee), and NIDA-K (Training Committee). Three Special Emphasis Panels were held to review applications in conflict with the chartered committees. Five Special Emphasis Panels were constituted for reviews of specific mechanisms: centers, program projects (two meetings), institutional development programs, and conference grants. Two additional Special Emphasis Panels were required for specific applications. In addition, OEA staff managed the reviews for B/START and Cutting Edge Basic Research Award mechanisms.
The following RFA review meetings were held:
| DA 01-004 |
The Transition from Drug Use to Addiction: Unearthing the Switch |
| DA 01-005 |
Health and Developmental Consequences of Prenatal Exposure to Methamphetamine
|
| DA 01-006 |
International Studies of HIV/AIDS |
| DA 01-007 |
HIV/AIDS and Drug Use Among Adolescents |
| DA 01-008 |
Health Disparities: Drug Use and Its Adverse Behavioral, Social, and Medical Consequences |
| DA 01-009 |
The Next Generation of Drug Abuse Prevention Research |
| DA 01-010 |
Responding to Club Drugs and Other Emerging and Current Drug Abuse Trends |
| DA 01-014 |
Research on GHB and Its Precursors |
| DA 01-015 |
Therapeutic Community Research |
The Contracts Review Branch managed the following reviews of proposals:
| N44DA-1-5514 |
State and Local Epidemiological Planning |
| N01DA-1-2200 |
Pharmacy and Clinical Support to the Clinical Trials Network |
| N01DA-1-2201 |
Administrative Support Center to the Clinical Trials Network |
| N01DA-1-9902 |
Subject Recruitment for NIDA Intramural Research Program |
| N44DA-1-5502 |
SA Prevention Program - Phase II SBIR |
| N01DA-1-1107 |
NIDA NOTES |
| N44DA-1-7701 |
Configure Gene Chips - Phase II SBIR |
| N01DA-1-8815 |
Synthesis Medicinal Chemistry |
| N01DA-1-8817 |
Pharmacokinetic Analysis Resource Center |
| N44DA-1-7700 |
JAVA Tool - MicroArrays |
| N01DA-1-1105 |
Research Dissemination |
| N01DA-1-1106 |
NIDA's Science Meetings Logistical Support |
| N01DA-1-8818 |
Regulatory Affairs Support |
In addition a concept for SBIR contract project N43DA-2-7726, Functional Imaging Agents, was reviewed.
Staff Training and Policy Development
The OEA Symposium Series continued its monthly meetings for staff development. In May 2001, staff raised a number of items for discussion from the scheduled "open floor" forum. In June 2001, Dr. Karin Johnson, of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA), presented on using the internet to provide ideas for NIDA activities. July 2001's meeting consisted of discussion of case studies, and August's meeting centered on a discussion of bioethics, led by Mr. Noble Jones, CAMCODA. In August 2001, Dr. Mark Swieter, SRA in the Basic Science Review Branch, OEA, assumed responsibility for organization of the OEA Symposium Series.
Dr. Teresa Levitin, Director, OEA, and Ms. Loretta Beuchert, Program Assistant, OEA, are compiling comments reviewers made about their participation in the Cutting-edge Basic Research Award (CEBRA) initiative. These comments will provide guidance as future procedures and policies related to CEBRA are developed.
[Office
of the Director][Report Index][Next
Report Section]
|
